738 related articles for article (PubMed ID: 15136973)
1. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
2. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
4. Role of oxidative stress in the natriuresis induced by central administration of angiotensin II.
Israel A; Arzola J; De Jesús S; Varela M
J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):9-14. PubMed ID: 19286753
[TBL] [Abstract][Full Text] [Related]
5. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
Geny B; Charloux A; Schaefer A; Brandt C; Charpentier A; Kretz JG; Eisenmann B; Haberey P; Piquard F
J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
[TBL] [Abstract][Full Text] [Related]
6. Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP.
Boric MP; Bravo JA; Corbalan M; Vergara C; Roblero JS
Biol Res; 1998; 31(3):281-9. PubMed ID: 9830516
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
8. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
Garcia R; Bonhomme MC; Diebold S
J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
[TBL] [Abstract][Full Text] [Related]
9. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
10. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
Liu C; Chen Y; Kang Y; Ni Z; Xiu H; Guan J; Liu K
J Pharmacol Exp Ther; 2011 Oct; 339(1):203-9. PubMed ID: 21737535
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.
Hakam AC; Hussain T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1430-6. PubMed ID: 16380464
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic action of ANP is blunted by ACE inhibition in humans.
Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
[TBL] [Abstract][Full Text] [Related]
14. [Central cardiovascular and renal effects of atrial natriuretic peptide].
Zhao G; Luo H; Ho SY
Sheng Li Xue Bao; 1991 Dec; 43(6):537-47. PubMed ID: 1839084
[TBL] [Abstract][Full Text] [Related]
15. Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway.
Oh YB; Gao S; Shah A; Kim JH; Park WH; Kim SH
Peptides; 2011 Feb; 32(2):374-81. PubMed ID: 21056071
[TBL] [Abstract][Full Text] [Related]
16. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
[TBL] [Abstract][Full Text] [Related]
17. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
18. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of angiotensin II, atrial natriuretic peptide and their interaction in man.
McMurray JJ; Struthers AD
J Hypertens Suppl; 1987 Dec; 5(5):S59-62. PubMed ID: 2965232
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide is involved in renal actions of moxonidine.
Mukaddam-Daher S; Gutkowska J
Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]